Jain Rita

CIK 00017077976 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001707797

Recent Transactions

50 trades

Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-06-15−1,300→ 0 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2024-06-15+4,534→ 4,534 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-06-15−3,234→ 0 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2024-06-13+16,500→ 16,500 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-01-03+6,030→ 6,030 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2024-01-03+16,510→ 16,510 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−66,000→ 0 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-04-03+3,900→ 3,900 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-04-03+10,600→ 10,600 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-04-03+3,234→ 3,234 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-04-03+8,015→ 8,015 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2023-02-16+17,100→ 17,100 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2023-01-03+66,000→ 66,000 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−307→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Restricted Stock Unit
2022-10-20−11,600→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−23,948→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−21,052→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−4,504→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−14,393→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−12,287→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−35,863→ 0 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2022-05-20−7,726→ 0 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2022-05-20+7,726→ 35,863 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2022-03-27+5,251→ 28,137 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2022-03-27−5,251→ 0 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2022-02-22+14,700→ 14,700 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2022-02-22+11,600→ 11,600 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2021-10-05+45,000→ 45,000 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2021-05-21+4,660→ 22,886 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2021-05-21−4,660→ 0 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2021-05-20+4,504→ 4,504 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2021-05-20+7,726→ 7,726 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2021-03-27+5,251→ 18,226 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2021-03-27−5,251→ 5,251 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2021-03-19+342,300→ 342,300 total
Award
Immunovant, Inc.$IMVT
Common Stock
2021-03-19+11,765→ 129,365 total
Award
Immunovant, Inc.$IMVT
Common Stock
2021-03-19+97,600→ 117,600 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2021-03-19+342,300→ 342,300 total
Award
Immunovant, Inc.$IMVT
Common Stock
2021-03-19+109,365→ 129,365 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2021-01-22+220,000→ 220,000 total
Award
Immunovant, Inc.$IMVT
Common Stock
2021-01-22+20,000→ 20,000 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2020-05-21+2,888→ 2,888 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2020-05-21+4,660→ 4,660 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2020-03-27+5,251→ 12,975 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2020-03-27−5,251→ 10,502 total
Award
ChemoCentryx, Inc.
Common Stock
2019-05-23+7,724→ 7,724 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2019-05-23+12,287→ 12,287 total
Disposition to Issuer
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-04-11$7.70/sh−4,409→ 96,332 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2019-03-27+15,753→ 15,753 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-02-28+80,000→ 100,741 total

Companies

Recent Filings

Address

C/O AKEBIA THERAPEUTICS, INC 245 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov